SUNDAY 22 OCTOBER 2023
08:00
Sponsored Diagnostic Symposium 1
More information will follow soon
Plenary session 3
Chairs: t.b.c.
09:00
PS3.1 Basic
Silke Schelenz, United Kingdom, FECMM
09:30
PS3.2 Diagnostics
Lewis White, United Kingdom, FECMM
10:00
PS3.3 Therapeutics
Donald Sheppard, Canada, FECMM
10:00
Coffee break
10:15
Meet the expert session [1 topic, 2 speakers]
10:15
M6 Rapid test for diagnosis of fungal infections
Souha Kanj, Lebanon, FECMM & Karl Dichtl, Austria
10:15
M7 Dermatophyte
Aleksandra Barac, Serbia, FECMM & Georgia Vrioni, Greece
10:15
M8 Cryptococcus
Monica Slavin, Australia, FECMM & Tihana Bicanic, United Kingdom, FECMM
10:15
M9 Systemic corticosteroids steroids as a risk factor for fungal infections
Ignacio Martin-Loeches, Ireland & Nina Khanna, Switzerland
10:15
M10 Standardization of fungal diagnostics
Amir Seyedmousavi, Iran, FECMM & Malgorzata Mikulska, Italy, FECMM
11:00
Poster session 2
12:00
Lunch
12:30
Sponsored Integrated Symposium 4
More information will follow soon
14:15
Parallel Symposia 14-18
Symposium 14: How to implement IFI surveillance?
Chairs: t.b.c.
14:15
S14.1 Could we coordinate Aspergillus resistance surveillance in Europe?
Paul Verweij, the Netherlands, FECMM
14:35
S14.2 Surveillance in Candida infections
Alexandre Alanio, France, FECMM
14:55
S14.3 Surveillance of fungal infection in LATAM?
Arnaldo Colombo, Brazil, FECMM
15:15
S14.4 Selected abstract
Symposium15 Epidemiological trends and management of chronic pulmonary aspergillosis (CPA) and allergic broncho-pulmonary aspergillosis (ABPA)
Chairs: t.b.c.
14:15
S15.1 Epidemiology and mycological tools for chronic aspergillosis (CPA & ABPA)
Jean-Pierre Gangneux, France, FECMM
14:35
S15.2 Clinical guidance and imaging for CPA diagnosis and follow-up
Cendrine Godet, France
14:55
S15.3 Consensus approaches of the management of CPA
Danila Seidel, Germany, FECMM
15:15
S15.4 Consensus approaches of the management of ABPA
Ritesh Agarwal, India
Symposium 16 Fungal infections in the ICU in patients with influenza and COVID-19
Chairs: t.b.c.
14:15
S16.1 Multi-omics for early diagnosis and risk stratification for viral associated pulmonary aspergillosis
Agostinho Carvalho, Portugal, FECMM
14:35
S16.2 Mechanisms of mucormycosis infection in COVID-19 patients
Ashraf Ibrahim, United States, FECMM
14:55
S16.3 Immunotherapy for fungal infections in the ICU – where do we stand?
Joost Wauters, Belgium, FECMM
15:15
S16.4 Selected abstract
Symposium 17 Fungal infections in paediatrics
Chairs: t.b.c.
14:15
S17.1 Global epidemiology of neonatal candidemia
Laura Ferreras-Antolin, United Kingdom
14:35
S17.2 Antifungal resistance in paediatrics
Zoi-Dorothea Pana, Cyprus, FECMM
14:55
S17.3 Antifungal prescription and stewardship in paediatrics
Elias Losifidis, Greece
15:15
S17.4 Selected abstract
Symposium 18 ECMM Excellence Centres (part 1)
14:15
S18.1 News ECMM Excellence Centres 1
Paul Bowyer, United Kingdom
14:25
S18.2 News ECMM Excellence Centres 1
Blandine Denis Bonvarlet, France
14:35
S18.3 News ECMM Excellence Centres 1
Andrej Spec, United States, FECMM
14:45
S18.4 News ECMM Excellence Centres 1
Dimitrios Kontoyiannis, United States, FECMM
14:55
S18.5 News ECMM Excellence Centres 1
Cornelia Lass-Flörl, Austria, FECMM
15:05
S18.6 News ECMM Excellence Centres 1
Eelco Meijer, the Netherlands
15:15
S18.7 News ECMM Excellence Centres 1
Philipp Köhler, Germany, FECMM
15:45
Coffee break
16:15
Parallel Symposia 19-23
Symposium 19 The current state of laboratory mycology and access to antifungal treatment across the world, an ECMM initiative
16:15
S19.1 Europe
Jon Salmanton-García, Germany, FECMM
16:35
S19.2 Africa
Rita Oladele, Nigeria, FECMM
16:55
S19.3 Asia Pacific
Sharon Chen, Australia, FECMM
17:15
S19.4 Latin-America
Alessandro Pasqualotto, Brazil, FECMM
Symposium 20 Management in haematological malignancies
Chairs: t.b.c.
16:15
S20.1 Primary and secondary prophylaxis
Livio Pagano, Italy, FECMM
16:35
S20.2 Pre emptive therapy
Thomas Walsh, United States, FECCM
16:55
S20.3 Breakthrough infections
Frederic Lamoth, Switzerland, FECMM
17:15
S20.4 Selected abstract
Symposium 21 ECMM Excellence Centres (part 2)
Chairs: t.b.c.
16:15
S21.1 News ECMM Excellence Centres 2
Robert Krause, Austria, FECMM
16:25
S21.2 News ECMM Excellence Centres 2
Jean-Pierre Gangneux, France, FECMM
16:35
S21.3 News ECMM Excellence Centres 2
Birgit Willinger, Austria, FECMM
16:45
S21.4 News ECMM Excellence Centres 2
Johannes Wagener, Ireland, FECMM
16:55
S21.5 News ECMM Excellence Centres 2
Jörg Steinmann, Germany, FECMM
17:05
S21.6 News ECMM Excellence Centres 2
Katrien Lagrou, Belgium, FECMM
17:15
S21.7 News ECMM Excellence Centres 2
t.b.c.
Symposium 22 Update on endemic mycosis
16:15
S22.1 Coccidioidomycosis
George Thompson, United States, FECMM
16:35
S22.2 Talaromycosis
Thuy Le, United States
16:55
S22.3 Paracoccidioidomycosis
Flavio de Queiroz Telles, Brazil, FECMM
17:15
S22.4 Endemic Mycoses emerging in Europe
Ferry Hagen, the Netherlands, FECMM
Symposium 23 Guidelines
Chairs: t.b.c.
16:15
S23.1 Aspergillus
Kauser Jabeen, Pakistan
16:35
S23.2 Candida
Matteo Bassetti, Italy
16:55
S23.3 Cryptococcus
John Perfect, United States
17:15
S23.4 Selected abstract
18:00
Sponsored Diagnostic Symposium 2
More information will follow soon
19:30
Congress dinner